Lilly CEO says Mounjaro shortage to end 'very soon'

By Reuters / Bloomberg
| August 02, 2024

Eli Lilly and Danish rival Novo Nordisk are racing to increase production in a weight-loss drug market estimated to reach about $150 billion by early 2030s.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Hospital leaders are increasingly turning to automation to streamline revenue cycle operations, but should some processes be left behind? ...